The company
Fulcrum Therapeutics, Inc.
FULC · Nasdaq
FULC stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 26.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 34
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $3.0M
- Insider sales, 12 months
- $59.7M
- Officials’ trades on record
- 0
- Institutions holding
- 148 (-13)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Kevin Tang10% owner | bought | 50,945at $3.52 | 17 Jul 2026filed 20 Jul 2026 |
| Kevin Tang10% owner | bought | 116,671at $3.56 | 16 Jul 2026filed 20 Jul 2026 |
| Kevin Tang10% owner | bought | 107,377at $3.56 | 15 Jul 2026filed 15 Jul 2026 |
| Kevin Tang10% owner | bought | 53,651at $3.56 | 14 Jul 2026filed 15 Jul 2026 |
| Kevin Tang10% owner | bought | 75,952at $3.58 | 14 Jul 2026filed 15 Jul 2026 |
| Kevin Tang10% owner | bought | 12,966at $3.54 | 13 Jul 2026filed 15 Jul 2026 |
| Alan EzekowitzDirector | sold | 18,000at $3.65 | 26 Jun 2026filed 30 Jun 2026 |
| Robert J. GouldDirector | sold | 15,000at $10.72 | 2 Feb 2026filed 4 Feb 2026 |
| Robert J. GouldDirector | sold | 15,000at $11.87 | 2 Jan 2026filed 6 Jan 2026 |
| Robert J. GouldDirector | sold | 15,000at $10.87 | 2 Jan 2026filed 4 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 8,824,259$32.3M | +3,433,666+63.7% |
| EcoR1 Capital, LLCnew · filed 14 Aug 2026 | 6,549,866$24.0M | +6,549,866 |
| TANG CAPITAL MANAGEMENT LLCnew · filed 14 Aug 2026 | 6,521,412$23.9M | +6,521,412 |
| Nantahala Capital Management, LLCadded · filed 14 Aug 2026 | 5,475,040$20.0M | +2,425,000+79.5% |
| MONTANOVA CAPITAL, LLCreduced · filed 14 Aug 2026 | 3,680,921$13.5M | -2,880,190−43.9% |
| D. E. Shaw & Co., Inc.added · filed 14 Aug 2026 | 3,044,385$11.1M | +1,421,104+87.5% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 2,704,505$9.9M | +1,412,019+109.2% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,697,216$9.9M | +4,268+0.2% |
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 2,217,498$8.1M | +1,907,081+614.4% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,037,025$7.5M | +487,174+31.4% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.